U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Methods for treating anxiety and panic

Patent 5792796 Issued on August 11, 1998. Estimated Expiration Date: Icon_subject August 11, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Cyclic amino acids
Patent #: 4024175
Issued on: 05/17/1977
Inventor: Satzinger ,   et al.

Treatment of cranial dysfunctions using novel cyclic amino acids
Patent #: 4087544
Issued on: 05/02/1978
Inventor: Satzinger, et al.

Novel methods for treating neurodegenerative diseases
Patent #: 5084479
Issued on: 01/28/1992
Inventor: Woodruff

Treatment of human diseases involving dysregulation or dysfunction of the nervous system Patent #: 5189026
Issued on: 02/23/1993
Inventor: Costa, et al.

Inventors

Application

No. 445398 filed on 06/06/1995

US Classes:

514/561, Nitrogen other than as nitro or nitroso nonionically bonded514/529, Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon514/530Z contains a cyclopentyl or cyclopentene ring

Examiners

Primary: Jarvis, William R. A.

Attorney, Agent or Firm

Foreign Patent References

  • 400665 EP. 12/13/1990
  • 92/22302 WO. 12/13/1992
  • 93/23383 WO. 11/13/1993

International Classes

A61K 031/195
A61K 031/215

Abstract

The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are useful in the treatment of anxiety and in the treatment and/or prevention of panic attacks.

Other References

  • D. Leiderman, et al., Epilepsia, 1993, 34:6, 45
  • S.B. Ellis, et al., Science, 1988, 241:1661-4
  • M. De Waard, et al., J. of Biological Chem, 1994, 269:9, 6716-6724
  • K.S. DeJongh, et al., J. of Biological Chem, 1990, 265:25, 14738-14741
  • P.-w Yuen, et al., Bioorg & Med Chem Lett, 1994, 4:6, 823-826
  • H. Tokumaru, et al., Eu J of Pharm-Molecular Pharm Section, 1992, 227:363-370
  • K.S. DeJongh, et al., Proc Natl Acad Sci USA, 1989, 86:8585-8589
  • International Search Report for PCT/US95/08702, 1996
  • Saletu, B., et al., Intl J of Clinical Pharm, Therapy & Tox, 1986, 24:7, 362-373
  • Isom, L.L., et al., Neuron, 1994, 12:1183-1194
  • Costall, B. et al., Pharm. Biochem & Behav, 1989, 32:777-785
  • Costall, B. et al., Br J Pharmacol, 1989, 96:312P
  • Field, M.J., et al., Br. J Pharmacol, 1991, 102:304P
  • Goa, K.L., et al., Drugs, 1993, 46:3, 409-427
  • Handley, S.L., et al., Naunyn-Schmiedeberg's Arch Pharmacol, 1984, 327:1-5
  • Hill, D.R., et al., Euro J of Pharm-Molecular Pharm Section, 1993, 244:303-309
  • Kilfoil, T., et al., Neuropharmacology, 1989, 28:9, 901-905
  • Pellow, S., et al., J. of Neuroscience Methods, 1985, 14:149-167
  • Singh, L., et al., Proc Natl Acad Sci USA, 1991, 88:1130-1133
  • Suman-Chauhan, N., et al., Euro J of Pharm-Molecular Pharm Section, 1993, 244:293-301
  • Andrews, J., et al., Lancet, 1990, 335:1114-1117
  • Oommen, K., et al., Neurology, 1993, 43:2292-229
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?